Chemical Biology and Drug Design to Understand and Overcome Antimicrobial Resistance
Our group uses synthetic chemistry to investigate how antimicrobial molecules behave in microbial cells and to design compounds that can overcome resistance. We make both drugs and chemical probes: fluorescent molecules that reveal where drugs go in living cells, and chemiluminescent molecules that report on bacterial enzyme activity.
These tools let us ask questions that are difficult to answer from antimicrobial activity alone. Does a drug reach its target? Does it accumulate in a particular compartment, or get diverted and degraded? Does uptake differ between susceptible and resistant strains? We use the answers to connect molecular structure with cellular behavior and, ultimately, with antimicrobial activity.

Seeing how antifungal drugs behave inside fungal cells
The activity of an antifungal drug depends on more than its ability to bind its target. Its uptake, intracellular distribution, and stability can also affect whether it reaches the right place in the cell. We develop fluorescent probes based on antifungal drugs to follow these processes in living pathogenic fungi.
For example, our fluorescent azole probes have been used to examine drug uptake and distribution across 60 Candida strains. The study revealed differences between species and strains, including variation in uptake, cell size, and subcellular localization. The more potent probe enantiomer showed a marked increase in uptake after about 150 minutes, while resistant strains with high drug efflux had distinct uptake patterns. In C. parapsilosis, the probe showed increased localization to lipid droplets. Together, these results show how live-cell imaging can expose differences in drug behavior that are not apparent from susceptibility measurements alone.
We have also developed probes based on the three clinically used polyene antifungals: amphotericin B, nystatin, and natamycin. Because the probes share a common design, we could compare how differences in the drug structures relate to their distribution in fungal cells. The probes showed distinct localization patterns, and resistant Candida strains showed enhanced accumulation of all three in the vacuole. This points to vacuolar sequestration as one possible contributor to polyene resistance and illustrates how resistance may involve altered drug handling within the cell, as well as changes to the drug target.
More broadly, we use chemical probes to investigate the mechanisms of antifungal drugs and to identify cellular behaviors associated with resistance. Current work extends this approach across antifungal drug classes and explores how probe design can help reveal structure–uptake–localization relationships in pathogenic fungi.
Echinocandins: from understanding drug trafficking to designing better drugs
Echinocandins inhibit β-(1,3)-glucan synthase, an enzyme complex needed to build the fungal cell wall. Resistance can arise through mutations in the FKS genes that encode part of this drug target. Our work examines both how echinocandins behave inside fungal cells and how chemical changes to the drugs may restore activity against resistant strains.
Fluorescent probes based on caspofungin, anidulafungin, and rezafungin showed that closely related echinocandins can behave differently in Candida cells. Caspofungin accumulated in the vacuole and was degraded there; anidulafungin remained at the cell surface, where its target is located, and was not degraded in the same way. Rezafungin showed a pattern that shifted between the cell surface and vacuole over time. These findings support the idea that drug localization can influence efficacy: a drug that reaches and remains near its target may behave differently from one that is diverted into a compartment where it is degraded.
We have also used chemical synthesis to reshape echinocandins and test their activity against strains carrying resistance-associated mutations. In a study of dehydroxylated derivatives, removal of the benzylic alcohol enhanced potency by as much as two orders of magnitude, depending on the particular FKS mutation. By contrast, removing a different alcohol group altered the drug’s conformation and reduced its efficacy. This work links specific structural features to activity against resistant strains and suggests routes for modifying the echinocandin scaffold.
Building on these findings, we are developing a new generation of echinocandin antifungals for invasive candidiasis. The goal is to design compounds that retain or improve activity against resistant fungi, including strains in which mutations reduce the effectiveness of existing drugs. This project brings together medicinal chemistry, resistance biology, and mechanistic understanding of how echinocandins interact with their target.
Chemiluminescent profiling of bacteria and yeast
We develop chemiluminescent probe arrays to characterize microbes through their enzymatic activity. Each probe reports on a particular activity, and the combined signals create a functional profile of the organism.
In bacteria, an array of 12 probes distinguished profiles across 29 strains, including Gram-positive and Gram-negative pathogens. The probes also detected enzyme activity associated with β-lactam resistance, and the profiling workflow produced results within 90 minutes.
We are extending this approach to pathogenic yeast. By adapting chemical probes to fungal biology, we aim to investigate how activity profiles vary among yeast strains and how they relate to antifungal resistance. This work is part of our broader effort to develop chemical tools that help characterize microbes and reveal resistance-associated differences.

Research
